EUVIMEDEUVIMED entdecken
Crossref

Anti-Breast Cancer Effects of Carbon Quantum Dots: In Vivo Angiogenesis and Arginase Co-Inhibition

Gurmeet Singh iD, Somedutta Maity, Desh Deepak Yadav iD, Taniya Das, Kirti Wasnik iD, Rajalaxmi Pradhan, Aman Srikant Kudada, Divya Pareek, Sukanya Patra, Anjali Mourya, Subrata Panda, Tarun Batra und 1 weitere

ACS Applied Bio Materials · 06.04.2026 · 9 (7) · 3310-3325

DOI: 10.1021/acsabm.5c02284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 17.03.2026. Verfasst von Gurmeet Singh und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Indian Institute of Technology (BHU), Varanasi, UP 221005, India. Hauptthemen laut MEDLINE: Carbon Quantum Dots, Arginase, Antineoplastic Agents, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Indian Institute of Science, Indian Council of Medical Research, Council of Scientific and Industrial Research, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer evades the immune system through immune-regulating enzymes. One of them is arginase, primarily produced in tumor-resident cells, especially by tumor-associated macrophages and myeloid-derived suppressor cells. This helps malignant tumors thrive and escape immune surveillance. However, targeting arginase is challenging because of its crucial role in the urea cycle. Pharmacological inhibitors of arginases have been linked to severe side effects in nitrogen metabolism, particularly hyperammonemia. Herein, therefore, we report on the arginase-inhibition-based in vitro and in vivo treatment of BC-bearing mice with carbon quantum dots (CQDs) derived from Azadirachta indica. These CQDs inhibit the arginase enzyme, thereby exhibiting anti-angiogenic and anti-proliferative properties. These CQDs contribute to 68 ± 5% remission of malignant tumors and 58 ± 5% inhibition of cell growth through arginase inhibition. This is particularly difficult to achieve with contemporary anti-cancer drugs. Protein upregulation of IFN-γ, IL-6, IL-8, IL-21, TLR4, LAT-1, T-cell marker, and IgG and downregulation of TNFα and IL-1β corroborate an increase in the anti-tumor immune response. Furthermore, histological results show an increase in the inhibition of cancer cells and an increase in immune cells after CQD treatment. Overall, the CQDs reported herein are paramount for the treatment of aggressive BC, which can further be used for the treatment of other cancers. The results further demonstrate that these CQDs can potentially be delivered to terminally ill patients who are not responding to contemporary therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbon Quantum DotsArginaseAntineoplastic AgentsBreast NeoplasmsNeovascularization, PathologicEnzyme InhibitorsAngiogenesis InhibitorsAnimalsFemaleMiceHumansCell ProliferationMaterials TestingDrug Screening Assays, AntitumorAzadirachtaParticle Size

Stichwörter der Autor:innen

CQDsangiogenesisanti-cancerarginaseimmunotherapy

Substanzen

ArginaseAntineoplastic AgentsEnzyme InhibitorsAngiogenesis Inhibitors

Autor:innen und Institutionen

  • School of Biomedical Engineering, Indian Institute of Technology (BHU), Varanasi, UP 221005, India.
  • School of Engineering Sciences and Technology, University of Hyderabad, Hyderabad, Telangana 500046, India.
  • Department of Ceramic Engineering, Indian Institute of Technology (BHU), Varanasi, UP 221005, India.
  • Department of Oncology, Institute of Medical Sciences (IMS), Banaras Hindu University, Varanasi, UP 221005, India.

ORCID-Profile: Gurmeet Singh, Desh Deepak Yadav, Kirti Wasnik, Pradip Paik

Förderung

  • Indian Institute of Science
  • Indian Council of Medical Research
  • Council of Scientific and Industrial Research, India
  • Science and Engineering Research Board

Zitieren

APA

Singh, G., Maity, S., Yadav, D. D., Das, T., Wasnik, K., Pradhan, R., Kudada, A. S., Pareek, D., Patra, S., Mourya, A., Panda, S., Batra, T., & Paik, P. (2026). Anti-Breast Cancer Effects of Carbon Quantum Dots: In Vivo Angiogenesis and Arginase Co-Inhibition. ACS Applied Bio Materials, 9(7), 3310-3325. https://doi.org/10.1021/acsabm.5c02284

Vancouver

Singh G, Maity S, Yadav DD, Das T, Wasnik K, Pradhan R, et al. Anti-Breast Cancer Effects of Carbon Quantum Dots: In Vivo Angiogenesis and Arginase Co-Inhibition. ACS Applied Bio Materials. 2026;9(7):3310-3325. doi:10.1021/acsabm.5c02284

BibTeX
@article{Singh2026,
  author = {Singh, Gurmeet and Maity, Somedutta and Yadav, Desh Deepak and Das, Taniya and Wasnik, Kirti and Pradhan, Rajalaxmi and Kudada, Aman Srikant and Pareek, Divya and Patra, Sukanya and Mourya, Anjali and Panda, Subrata and Batra, Tarun and Paik, Pradip},
  title = {Anti-Breast Cancer Effects of Carbon Quantum Dots: In Vivo Angiogenesis and Arginase Co-Inhibition},
  journal = {ACS Applied Bio Materials},
  year = {2026},
  volume = {9},
  number = {7},
  pages = {3310--3325},
  doi = {10.1021/acsabm.5c02284}
}
Kostenlos starten →